Adverse event risk signal mining of ipilimumab based on the US FDA Adverse Event Reporting System

Zhang Yalan, Hong Wencong, Chen Qiying

PDF(447 KB)
PDF(447 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (11) : 656-661. DOI: 10.3760/cma.j.cn114015-20230410-00261

Adverse event risk signal mining of ipilimumab based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(11): 656-661 https://doi.org/10.3760/cma.j.cn114015-20230410-00261

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(447 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉